Home Trending Stocks Cassava Sciences, Inc. (SAVA) Stock Prices on the Rise After Success of...

Cassava Sciences, Inc. (SAVA) Stock Prices on the Rise After Success of Clinical Trials

Cassava Sciences, Inc. (SAVA) stock prices were up 5.61% as of market close on April 26th 2021, bringing the price per share up to USD$41.81 at the end of the trading day. Subsequent current market fluctuations saw the stock price climb 3.78% to it USD$43.39.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

SAVA’s Net Loss

In their recently disclosed financial reports for Q1 2021, SAVA reported a net loss of USD$3.5 million, a significant increase from their reported net loss of USD$1.2 million in the same period over the previous year. Net loss per share came out to USD$0.09 for Q1 2020, an increase from the USD$0.05 net loss per share reported in Q1 2020.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Read More

SAVA’s Registered Direct Offering

Earlier in February 2021, SAVA announced the closing of its registered direct offering. The offering saw the company put up 4,081,633 shares of its common stock for sale, at a price per share of USD$49. Gross proceeds came out to nearly USD$200 million, with net proceeds of roughly USD$189.7 million after the deduction of costs associated with the offering.

Solid Liquidity Position for SAVA

The company reported USD$282.2 million in cash and cash equivalents as of March 31st 2021, with no outstanding debt. This is compared to the USD$93.5 reported as of December 31st, 2020. SAVA anticipates net cash use for upcoming operations throughout 2021 to be up to USD$25 million. This capital is anticipated to be allocated to personnel expenses associated with an increased workforce, manufacturing costs for the large-scale supply of drugs, and costs associated with clinical programs.

Positive Interim Analysis of Simufilam

On February 2nd, 2021, SAVA announced positive results for the first interim analysis that reported clinical data on a patient cohort being treated with simufilam. The cohort comprised the first 50 patients to have completed 6 months of open label treatment, with patients’ cognition scores having improved from baseline over the course of the 6 months of simufilam treatment. Consistent treatment presented no safety issues and showed a 10% mean improvement in cognition score from baseline to month 6.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for SAVA

Especially interesting is the company’s foray into the development of a treatment for the COVID-19 virus that is ravaging the global economy. Should the company be as successful in that endeavor as they have been in their other clinical trials, the outcome could be massively lucrative for SAVA and its investors. Investors are hopeful that the company will leverage its sturdy financial grounds and recent clinical progress to push for significant and sustained increases in shareholder value over the course of 2021.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Tonix Pharmaceutics Holdings Inc. (TNXP) stock gains during current market. What’s driving it high?

Tonix Pharmaceuticals Holdings Inc. (TNXP) stock gains by 2.81% in the current market trading session. Tonix is a clinical-stage biopharmaceutical business dedicated on finding,...

Intec Pharma Inc. (NTEC) stock declines during current market after a massive upraise. What’s happening?

Intec Pharma Inc. (NASDAQ: NTEC) stock drops by 7.88% during the current market trading session. Intec Pharma is a clinical-stage biopharmaceutical firm specializing in...

Related News

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Drive Shack Inc. (DS) stock soars during after-hour trading, followed by no recent update

Drive Shack Inc. (NASDAQ: DS) stock declined by 3.94% at last close while the DS stock-price surged by 7.38% in the after-hour session. Drive...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam